Tomas Leanderson
Corporate Officer/Principal presso University of Lund
Profilo
Tomas Leanderson is a Professor of Immunology at the University of Lund, where he has been employed since 1990.
He was previously the President, Co-Chief Executive Officer, and IR Contact at Active Biotech AB from 2008 to 2017.
He also served as a Director at ProNoxis AB.
Leanderson earned a doctorate degree from Umea Universitet.
Posizioni attive di Tomas Leanderson
| Società | Posizione | Inizio |
|---|---|---|
| University of Lund | Corporate Officer/Principal | 06/05/2010 |
Precedenti posizioni note di Tomas Leanderson
| Società | Posizione | Fine |
|---|---|---|
| ACTIVE BIOTECH AB | Amministratore Delegato | 01/07/2017 |
ProNoxis AB
 ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Direttore/Membro del Consiglio | - |
Formazione di Tomas Leanderson
| Umea Universitet | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ACTIVE BIOTECH AB | Health Technology |
| Aziende private | 1 |
|---|---|
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology ProNoxis AB develops small-molecule drugs to treat chronic inflammation. The company was founded in 2009 and is headquartered in Lund, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Tomas Leanderson
